“(EU trade mark – Invalidity proceedings – EU word mark BREZTRI – Earlier EU word marks ONBREZ, BREZILIZER and BREEZHALER – No likelihood of confusion – Lack of enhanced distinctiveness of the earlier…”
You're reading the free summary of Novartis v EUIPO - AstraZeneca (BREZTRI) (EU trade mark - BREZTRI - Judgment). Create a free account to unlock the full reasoning, the cited authorities and the verbatim judgment — plus structured briefs for 412,000+ UK judgments.
No card required. Free forever.
Multiple official and mirror sources — pick whichever loads cleanly on your network.
Falls back to Google for old citations BAILII catalogues separately
Common Room
0 comments · About the Common Room →
No comments yet — start the discussion.
Voted-best comments help future students and feed Caselaw's AI study tools.